The 2004 Implant Yearbook on Orthopaedic Endoprostheses
|
|
|
- Flora Ford
- 10 years ago
- Views:
Transcription
1 Publicatios of the Natioal Agecy for Medicies 2/2006 The 2004 Implat Yearbook o Orthopaedic Edoprostheses Fiish Arthroplasty Register Pekka Ratae Aeli Keioe Aui Mäkelä
2 The 2004 Implat Yearbook o Orthopaedic Edoprostheses Fiish Arthroplasty Register Pekka Ratae Aeli Keioe Aui Mäkelä Distributio: Natioal Agecy for Medicies P.O. Box 55, FI Helsiki FINLAND Tel Fax Orders: [email protected] ISSN ISBN ISBN Prit: Tikkurila paio Oy, Vataa
3 Foreword Dear Reader The Fiish Arthroplasty Register has a log history. The Register was origially fouded by the Fiish Associatio of Orthopaedic Surgeos ad sice 1980 has collected iformatio cocerig orthopaedic edoprosthetic surgery. Juha Nevalaie, M.D., the previous editor-i-chief, started to publish the data collected systematically, thus brigig this iformatio ito cliical use ad to assist decisio-makig. Over the years, the structure of this publicatio has become established ad its readers leared to use it to search for the iformatio they eeded. This is testified by the fact that the last editio is almost sold out, the coutless dowloads from our website ad the may eager requests for a ew Yearbook. Dr. Juha Nevalaie has really doe groud-breakig work ad deserves the warmest thaks from us all. For the ew editor-i-chief it has bee easy to build o the previous publicatios. O the other had, there have bee distict difficulties i brigig some ew perspectives to existig iformatio whilst keepig the readers happy. The aim was to streamlie the book, to make it easier to read ad, perhaps, to provide some ew iformatio. At the same time, the purpose was to preserve iformatio that the readers have become familiar with. A ew feature is that the comparability of a sigle edoprosthesis to other edoprostheses by survival curves is ow possible at a glace. The structure of the tables places more emphasis o the preset data rather tha the historical iformatio that still has bee preserved. I additio, there is a attempt to take a look ahead by assessig future treds i orthopaedic edoprosthetic surgery. This assessmet was based o curret operatio statistics i the populatio over 40 years. The assumptio was that characteristic operatio umbers will remai costat i each age group ad thus the forecast will oly reflect the ifluece of the populatio ageig. It is comprehesible that this type of forecast fails to take ito accout progress made i treatmet methods ad the chage i the icidece of osteoarthritis ad other joit diseases. The assessmet of these issues will remai beyod the scope of this publicatio. Still, this forecast shows that it is ot possible to eglect the growig problem of multiple joit diseases. It is importat to remid the reader that this publicatio is ot a scietific oe but merely a descriptio of the cotet of the Register. Iterpretatio of the figures thus remais solely the resposibility of the reader. Nevertheless, aalytical methods are widely used i medical statistics. The descriptio of some methods that are ot self-evidet ca be dowloaded from our website. Cofidece itervals (95%) are widely used i survival curves ad the upper limit is show as CI_max ad lower limit CI_mi, correspodigly. The reader may become embarrassed by the fact that edoprosthetic survival just after implatatio is worse after 1996 tha it was earlier. This declie is based o the chage i data recordig methods. Before 1996, the early problems after edoprosthetic surgery were cosidered as primary complicatios eve though they resulted i a ew operatio ad revisio arthroplasty. Sice the, ew surgical procedure less tha 4 moths after the primary oe has bee similarly viewed as other subsequet operatios. Cosequetly, the survival curves reveal more clearly the early problems of edoprosthetic surgery tha the previous recordig method. Still, all differet moder edoprostheses are assessed i the same way. We hope this iformatio will give a more realistic picture of the early results of edoprosthetic surgery. Therefore, we have added some ew figures as a survival curve for shoulder, akle ad elbow edoprostheses, too. I have bee pleased to receive may wishes for the future developmet of the Register, its data cotet ad the form of the preset publicatio. Some of these wishes will materialise i the form of scietific published studies. Ufortuately, it is ot possible to fulfil most of these wishes due to the atioal ature of the Register. It is importat to maitai comparability of the curret data to the previous oe. All chages i the Register cotet will ecessitate atioal chages i data collectig ad trasfer systems. Such chages are time ad labour cosumig. It is probably ot possible to make major chages util data collectig, processig ad trasmissio systems have become automatic alog with atioal electroic patiet records. The data cotet of the Register has frequetly bee compared to other cetralised atioal patiet registers i the Natioal Research ad Developmet Cetre for Welfare ad Health (Stakes) by comparig the few overlappig data. The coverage of the Register data cotet has repeatedly bee excellet: some of our data is lackig from Stakes ad vice versa. The Register covers practically 100% of Fiish arthroplasties. Thus, the lackig data does ot affect the essetial iformatio that ca be extracted from the Register data. Such exceptioal coverage i the data cocerig early after surgery data would ot be possible without the work of umerous people workig i operatio theatres ad hospital departmets. However, the data cocerig the later stages of the patiet history is probably ot complete ad should thus be treated with cautio. Co-operatio with Stakes has expaded the data cotet of the preset publicatio. Stakes has e.g. produced iformatio cocerig the time spet i hospital at the time of arthroplasty. It is ecouragig that this time has slightly decreased durig the past 10 years. Whether this is the reaso for the cocomitat decrease i otified early complicatios or whether the complicatio rate really has decreased remais obscure. Mr. Simo Pelateri is ackowledged for his work i processig the data i Stakes. I wat to express my thaks to Mr. Jyrki Kettue, Ph.D. for his help i estimatig future surgical treds, to my colleagues i the Departmet of Medical Devices ad to the Natioal Agecy for Medicies that has agai made the publicatio of this data possible. Fially, I have to metio System Aalyst Aeli Keioe who has mostly bee resposible for the statistical aalysis ad creatig publishable data; ad Register Secretary Aui Mäkelä who has checked ad recorded the origial data ad checked the figures. I additio, she has give may ivaluable hits for the improvemet of this publicatio. They both deserve my warmest thaks for their prompt work. Pekka Ratae, M.D. Seior Medical Officer
4 Cotets G1a. Total Joit Arthroplasty operatios performed i differet muicipalities / ihabitats i G1b. Total Joit Arthroplasty operatios performed i differet muicipalities / ihabitats average of the year Figure G3. Predicted umber of primary hip ad kee joit arthroplasty operatios by 2030 i the populatio over 40 years 9 Figure G4. The umber of revisio arthroplasties 9 Table 1. Total joit arthroplasty procedures betwee i differet hospitals 10 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Figure L1. The umber of total hip arthroplasties betwee Figure L2. Primary hip joit arthroplasties i me betwee i differet age groups 25 Figure L3. Primary hip joit arthroplasties i wome betwee i differet age groups 25 Figure L4. Idicatios for primary total hip arthroplasties betwee Figure L5. Complicatio rate i primary hip joit arthroplasties betwee Figure L6. The average legth of hospitalisatio due to edoprosthetic surgery i hip osteoarthritis, me 27 Figure L7. The average legth of hospitalisatio due to edoprosthetic surgery i hip osteoarthritis, wome 27 Figure L8. Primary total hip joit arthroplasties i differet types of hospitals betwee Figure L9. Total hip joit revisio arthroplasties i differet types of hospitals betwee Figure L10. Total hip joit arthroplasties i primary osteoarthritis betwee Figure L11. The use of cemeted fixatio techique of prosthetic compoets i primary total hip arthroplasties betwee Figure L12. Total hip joit edoprostheses i primary osteoarthritis betwee Figure L13. Atibiotic prophylaxis i primary hip joit operatios betwee Figure L14. Hip joit arthroplasty revisios i me durig i differet age groups 31 Figure L15. Hip joit arthroplasty revisios i wome betwee i differet age groups 31 Figure L16. Idicatios for total hip joit arthroplasty revisios i Figure L17. Allograft ad autograft i hip joit revisios betwee Figure L18. Total hip joit edoprostheses i primary osteoarthritis, first revisio betwee Figure L19. Aual umber of hip joit revisio arthroplasties due to ifectio 33 Figure L20. Time to revisio arthroplasty after the removal of the hip joit edoprosthesis due to ifectio 34 Figure L21. The proportio of the first, the secod ad the third total hip joit revisio operatios i Table 3a. Primary hip joit arthroplasties i me with rheumatoid arthritis betwee Table 3b. Primary hip joit arthroplasties i wome with rheumatoid arthritis betwee Figure L22. Total hip joit edoprostheses i rheumatoid arthritis betwee Figure L23. Total hip joit edoprostheses i rheumatoid arthritis, first revisio betwee Table 4. Total hip joit edoprostheses i primary arthroplasties betwee Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs 42 Figure L24a. EXETER UNIVERSAL+ ABG II cup hip prosthesis i primary operatios betwee Figure L24b. EXETER UNIVERSAL+ ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee Me 50 Figure L24c. EXETER UNIVERSAL+ ABG II cup hip prosthesis i primary osteoarthritis betwee Wome 51 Figure L25a. EXETER UNIVERSAL + CONTEMPORARY cup hip edoprosthesis i primary arthroplasties betwee Figure L25b. EXETER UNIVERSAL + CONTEMPORARY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 52 Figure L25c. EXETER UNIVERSAL+ CONTEMPORARY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 53 Figure L25e. EXETER UNIVERSAL + CONTEMPORARY cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 53 Figure L26a. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary arthroplasties betwee Figure L26b. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 54 Figure L26c. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 55 Figure L26e. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 55
5 Figure L27a. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary arthroplasties betwee Figure L27b. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 56 Figure L27c. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 57 Figure L28a. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary arthroplasties betwee Figure L28b. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 58 Figure L28c. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 59 Figure L28e. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 59 Figure L29a. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary arthroplasties betwee Figure L29b. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary osteoarthritis betwee Me 60 Figure L29c. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary osteoarthritis betwee Wome 61 Figure L30a. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary arthroplasties betwee Figure L30b. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary osteoarthritis betwee Me 62 Figure L30c. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary osteoarthritis betwee Wome 63 Figure L30e. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i rheumatoid arthritis betwee Wome 63 Figure L31a. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary arthroplasties betwee Figure L31b. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 64 Figure L31c. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 65 Figure L32a. ABG II + ABG II cup hip joit edoprosthesis i primary arthroplasties betwee Figure L32b. ABG II + ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 66 Figure L32c. ABG II + ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 67 Figure L33a. BIRMINGHAM + BIRMINGHAM cup hip joit edoprosthesis i primary arthroplasties betwee Figure L33b. BIRMINGHAM+ BIRMINGHAM cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 68 Figure L33c. BIRMINGHAM+ BIRMINGHAM cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 69 Figure P1. Primary ad revisio total kee joit arthroplasties betwee Figure P2. Primary kee arthroplasties i differet age groups i me betwee Figure P3. Primary kee arthroplasties i differet age groups i wome betwee Figure P4. Primary idicatios for total kee joit arthroplasties betwee Figure P5. Complicatio rate i primary kee joit arthroplasties betwee Figure P6. The average legth of hospitalisatio due to edoprosthetic surgery i kee osteoarthritis, me 73 Figure P7. The average legth of hospitalisatio due to edoprosthetic surgery i kee osteoarthritis, wome 73 Figure P8. Primary total kee joit arthroplasties i differet types of hospitals betwee Figure P9. Total kee joit revisio arthroplasties i differet types of hospitals betwee Figure P10. Total kee edoprostheses i primary osteoarthritis betwee Figure P11. The use of cemeted fixatio techique of prosthetic compoets i primary kee arthroplasties betwee Figure P12. Kee edoprostheses i primary osteoarthritis betwee Figure P13. Atibiotic prophylaxis i pimary kee arthroplasties betwee Figure P14. Kee arthroplasty revisios i differet age groups i me betwee Figure P15. Kee arthroplasty revisios i differet age groups i wome betwee Figure P16. Idicatios for total kee joit arthroplasty revisios i
6 Figure P17. Allograft ad autograft i kee revisios betwee Figure P18. Total kee joit edoprostheses i primary osteoarthritis, first revisio betwee Figure P19. The proportio of the first, the secod ad the third total kee joit revisio operatios i Table 6a. Primary kee arthroplasties i me with rheumatoid arthritis betwee Table 6b. Primary kee arthroplasties i wome with rheumatoid arthritis betwee Figure P20. Total kee joit edoprostheses i rheumatoid arthritis betwee Figure P21. Total kee joit edoprostheses i rheumatoid arthritis, first revisio betwee Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Figure P22a. DURACON kee edoprosthesis i primary arthroplasties betwee Figure P22b. DURACON kee joit edoprosthesis i primary osteoarthritis betwee , Me 87 Figure P22c. DURACON kee joit edoprosthesis i primary osteoarthritis betwee , Wome 88 Figure P22d. DURACON kee joit edoprosthesis i rheumatoid arthritis betwee , Me 88 Figure P22e. DURACON kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 89 Figure P23a. AGC V2 kee joit edoprosthesis i primary arthroplasties betwee Figure P23b. AGC V2 kee joit edoprosthesis i primary osteoarthritis betwee , Me 90 Figure P23c. AGC V2 kee joit edoprosthesis i primary osteoarthritis betwee , Wome 91 Figure P23d. AGC V2 kee joit edoprosthesis i rheumatoid arthritis betwee , Me 91 Figure P23e. AGC V2 kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 92 Figure P24a. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary arthroplasties betwee Figure P24b. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary osteoarthritis betwee , Me 93 Figure P24c. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary osteoarthritis betwee , Wome 94 Figure P25a. P.F.C SIGMA kee joit edoprosthesis i primary arthroplasties betwee Figure P25b. P.F.C SIGMA kee joit edoprosthesis i primary osteoarthritis betwee , Me 95 Figure P25c. P.F.C SIGMA kee joit edoprosthesis i primary osteoarthritis betwee , Wome 96 Figure P25e. P.F.C SIGMA kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 96 Figure P26a. P.F.C SIGMA STAB kee joit edoprosthesis i primary arthroplasties betwee Figure P26b. P.F.C SIGMA STAB kee joit edoprosthesis i primary osteoarthritis betwee , Me 97 Figure P26c. P.F.C SIGMA STAB kee joit edoprosthesis i primary osteoarthritis betwee , Wome 98 Figure P27a. NEXGEN LPS kee joit edoprosthesis i primary arthroplasties betwee Figure P27b. NEXGEN LPS kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 Figure P27c. NEXGEN LPS kee joit edoprosthesis i primary osteoarthritis betwee , Wome 100 Figure P28a. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary arthroplasties betwee Figure P28b. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary osteoarthritis betwee , Me 101 Figure P28c. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary osteoarthritis betwee , Wome 102 Figure P29a. MAXIM PRIMARY kee joit edoprosthesis i primary arthroplasties betwee Figure P29b. MAXIM PRIMARY kee joit edoprosthesis i primary osteoarthritis betwee , Me 103 Figure P29c. MAXIM PRIMARY kee joit edoprosthesis i primary osteoarthritis betwee , Wome 104 Figure P30a. ARGE kee joit edoprosthesis i primary arthroplasties betwee Figure P30b. ARGE kee joit edoprosthesis i primary osteoarthritis betwee , Me 105 Figure P30c. ARGE kee joit edoprosthesis i primary osteoarthritis betwee , Wome 106 Figure P31a. NEXGEN CR kee joit edoprosthesis i primary arthroplasties betwee Figure P31b. NEXGEN CR kee joit edoprosthesis i primary osteoarthritis betwee , Me 107 Figure P31c. NEXGEN CR kee joit edoprosthesis i primary osteoarthritis betwee , Wome 108 Figure P32a. DURACON Stabilizer box kee joit edoprosthesis i primary arthroplasties betwee Figure P32b. DURACON stabilizer box kee joit edoprosthesis i primary osteoarthritis betwee , Me 109 Figure P32c. DURACON Stabilizer box kee joit edoprosthesis i primary osteoarthritis betwee , Wome 110 Figure M1. Primary ad revisio arthroplasties of other joit operatios betwee Figure M2. Primary arthroplasties of other joits i Figure M3. Primary idicatios for arthroplasties of other joits betwee Figure M4. Shoulder prostheses i primary arthroplasties betwee Figure M5. Akle prostheses i primary arthroplasties betwee Figure M6. Elbow prostheses i primary arthroplasties betwee Figure M7. Idicatios for revisio arthroplasties of other joits i FORMS Notificatio to the implat register; orthopaedic edoprostheses 115 Notificatio to the implat register; log-term complicatios 117
7 G1a. Total Joit Arthroplasty operatios performed i differet muicipalities / ihabitats i 2004 G1b. Total Joit Arthroplasty operatios performed i differet muicipalities / ihabitats average of the year Copyright Geimap, L6694/06 8
8 Figure Figure G3. Predicted G3. Predicted umber umber of primary of hip primary ad kee hip joit ad arthroplasty kee joit operatios arthroplasty by 2030 operatios i the populatio by 2030 over 40 years i the populatio over 40 years Number of operatios Kee Hip Hip ad kee joit together Year Figure G4. The umber of revisio arthroplasties, Figure G4. The umber of revisio arthroplasties, by courtesy of STAKES by courtesy of STAKES Hip revisio arthroplasties, all Kee revisio arthroplasties, all 1000 Number Year 9
9 Table 1. Total joit arthroplasty procedures betwee i differet hospitals Cotiued HOSPITAL DISTRICT HOSPITAL HIP KNEE OTHER JOINT Helsiki ja Uusimaa HUS / Surgical Hospital Peijas Hospital Hyvikää Hospital Jorvi Hospital Porvoo Hospital Lohja Regioal Hospital Läsi-Uusimaa Hospital HUS / Töölö Hospital / Otrhopedics HUS Varsiais-Suomi Turku Uiversity Cetral Hospital Salo Regioal Hospital Loimaa Regioal Hospital Turumaa Hospital Vakka-Suomi Hospital Raisio Regioal Hospital Turku Surgical Hospital Satakuta Satakuta Cetral Hospital Rauma Regioal Hospital Kata-Häme Kata-Häme Cetral Hospital Forssa Hospital Louais-Häme Regioal Hospital Riihimäki Regioal Hospital
10 Table 1. Total joit arthroplasty procedures betwee i differet hospitals Cotiued HOSPITAL DISTRICT HOSPITAL HIP KNEE Pirkamaa Tampere Uiveristy Hospital Valkeakoski Hospital Vammala Regioal Hospital Hatapää Hospital OTHER JOINT Päijät-Häme Päijät-Häme Cetral Hospital Heiola Health Cetre Lahti Health Cetre Kymelaakso Kymelaakso Cetral Hospital Kuusakoski Regioal Hospital Hamia Hospital Etelä-Karjala South Karelia Cetral Hospital Etelä-Savo Mikkeli Cetral Hospital Pieksämäki Hospital Pieksämäki Regioal Hospital Itä-Suomi Savolia Cetral Hospital Pohjois-Karjala North Karelia Cetral Hospital Pohjois-Savo Kuopio Uiversity Hospital Iisalmi Regioal Hospital Varkaus Regioal Hospital Keski-Suomi Cetral Filad Cetral Hospital Jokilaakso Hospital
11 Table 1. Total joit arthroplasty procedures betwee i differet hospitals Cotiued HOSPITAL DISTRICT HOSPITAL HIP KNEE OTHER JOINT Etelä-Pohjamaa Seiäjoki Cetral Hospital Ähtäri Hospital Vaasa Vaasa Cetral Hospital Pietarsaari Hospital Selkämeri Hospital Keski-Pohjamaa Keski-Pohjamaa Cetral Hospital Pohjois-Pohjamaa Oulu Uiversity Hospital Oulaskakas Hospital Raahe Hospital Kuusamo Health Cetre Hospital Raahe Regioal Hospital Kaiuu Kaiuu Cetral Hospital Läsi-Pohja Läsi-Pohja Cetral Hospital Lappi Lappi Cetral Hospital Hospital Lappoia Kemijärvi Regioal Hospital Ahveamaa Ålad Cetral Hospital
12 Table 1. Total joit arthroplasty procedures betwee i differet hospitals Cotiued HOSPITAL DISTRICT HOSPITAL HIP KNEE OTHER JOINT Private Hospitals COXA Orto Orthopaedic Hospital Rheuma Foudatio Hospital Hospital of the Oulu Deacoess Istitute Hospital Pulssi Eira Hospital Kutohovi Lääkäriasema Oy Itä-Suomi Medical Cetre Diacor Hospital Hospital Lasaretti Pirkamaa Surgical Cliic Hospital Mehiläie Turku Hospital Mehiläie Helsiki Hospital Botia Oy Pori Medical Cetre Hospital Dextra Mukkivuori Hospital of the Oulu Deacoess Istitute/ Oulu Uiversity Hospital Cetral Military Hospital
13 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Alahärmä Alajärvi Alastaro Alavieska Alavus Ajalakoski Artjärvi Asikkala Askaie Askola Aura Brädö Dragsfjärd Eckerö Elimäki Eo Eokoski Eotekiö Espoo Eura Eurajoki Evijärvi Fiström Forssa Föglö Geta Haapajärvi Haapavesi Hailuoto Halikko Halsua Hamia Hammarlad Hakasalmi Hako Harjavalta Hartola Hattula Hauho Haukipudas Haukivuori Hausjärvi Heiola Heiävesi Helsiki
14 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Himaka Hirvesalmi Hollola Hokajoki Houtskari Huittie Humppila Hyrysalmi Hyvikää Hämeekoski Hämeekyrö Hämeelia Ii Iisalmi Iitti Ikaalie Ilmajoki Ilomatsi Imatra Iari Iiö Ikoo Isojoki Isokyrö Jaala Jalasjärvi Jaakkala Joesuu Jokioie Jomala Joroie Joutsa Joutseo Juakoski Jurva Juuka Juupajoki Juva Jyväskylä Jyväskylä mlk Jämijärvi Jämsä Jämsäkoski Järvepää Kaaria
15 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Kaavi Kajaai Kalajoki Kalvola Kagasala Kagaslampi Kagasiemi Kakaapää Kaokoski Kaus Karijoki Kariaie Karjaa Karjalohja Karkkila Karstula Karttula Karvia Kaskie Kauhajoki Kauhava Kauiaie Kaustie Keitele Kemi Kemijärvi Kemimaa Kemiö Kempele Kerava Kerimäki Kestilä Kesälahti Keuruu Kihiö Kiihtelysvaara Kiikala Kiikoie Kiimiki Kiula Kirkkoummi Kisko Kitee Kittilä Kiukaie
16 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Kiuruvesi Kivijärvi Kodisjoki Kokemäki Kokkola Kolari Koevesi Kotiolahti Korpilahti Korppoo Korsäs Kortesjärvi Koski TL Kotka Kouvola Kristiiakaupuki Kruuupyy Kuhmalahti Kuhmo Kuhmoie Kuivaiemi Kullaa Kumlige Kuopio Kuortae Kurikka Kuru Kustavi Kuusamo Kuusakoski Kuusjoki Kylmäkoski Kyyjärvi Kälviä Kärkölä Kärsämäki Kökar Köyliö Lahti Laihia Laitila Lammi Lapijärvi Lapilahti Lappajärvi
17 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Lappeerata Lappi Lapua Laukaa Lavia Lehtimäki Leivomäki Lemi Lemlad Lempäälä Lemu Leppävirta Lestijärvi Lieksa Lieto Liljedal Limika Liperi Lohja Lohtaja Loimaa Loimaa kuta Loppi Loviisa Luhaka Lumijoki Lumparlad Luopioie Luoto Luumäki Luvia Lägelmäki Maalahti Maaika Maariahamia Maksamaa Marttila Masku Mellilä Merijärvi Merikarvia Merimasku Miehikkälä Mietoie Mikkeli
18 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Mouhijärvi Muhos Multia Muoio Mustasaari Muurame Muurla Myämäki Myrskylä Mätsälä Mättä Mätyharju Naatali Nakkila Nastola Nauvo Nilsiä Nivala Nokia Noormarkku Nousiaie Nummi-Pusula Nurmes Nurmijärvi Nurmo Närpiö Oravaie Orimattila Oripää Orivesi Oulaie Oulu Oulusalo Outokumpu Padasjoki Paimio Paltamo Paraie Parikkala Parkao Pattijoki Pedersöre Pelkoseiemi Pello Perho
19 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Peraja Periö Pertteli Pertumaa Peräseiäjoki Petäjävesi Pieksämäki Pieksämaa Pielavesi Pietarsaari Pihtipudas Piikkiö Piippola Pirkkala Pohja Polvijärvi Pomarkku Pori Poraie Porvoo Posio Pudasjärvi Pukkila Pulkkila Pukaharju Pukalaidu Puolaka Puumala Pyhtää Pyhäjoki Pyhäjärvi Pyhätä Pyhärata Pyhäselkä Pylkömäki Pälkäe Pöytyä Raahe Raisio Ratasalmi Ratsila Raua Rauma Rautalampi Rautavaara
20 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Rautjärvi Reisjärvi Reko Riihimäki Ristiia Ristijärvi Rovaieme mlk Rovaiemi Ruokolahti Ruotsipyhtää Ruovesi Rusko Ruukki Rymättylä Rääkkylä Saari Saarijärvi Sahalahti Salla Salo Saltvik Sammatti Sauvo Savitaipale Savolia Savorata Savukoski Seiäjoki Sievi Siikaie Siikajoki Siilijärvi Simo Sipoo Siutio Sodakylä Soii Somero Sokajärvi Sotkamo Sottuga Sulkava Sumiaie Sud Suodeiemi
21 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Suolahti Suomeiemi Suomusjärvi Suomussalmi Suoejoki Sysmä Säkylä Särkisalo Taipalsaari Taivalkoski Taivassalo Tammela Tammisaari Tampere Tarvasjoki Temmes Tervo Tervola Teuva Tohmajärvi Toholampi Toijala Toivakka Torio Turku Tuulos Tuupovaara Tuusiemi Tuusula Tyrävä Töysä Ullava Ulvila Urjala Utajärvi Utsjoki Uukuiemi Uuraie Uusikaarlepyy Uusikaupuki Vaala Vaasa Vahto Valkeakoski Valkeala
22 Table 2. The umber of total joit arthroplasty procedures i all muicipalities betwee Cotiued MUNICIPALITY Valtimo Vammala Vampula Vataa Varkaus Varpaisjärvi Vehmaa Vehmersalmi Velkua Vesato Vesilahti Veteli Vieremä Vihati Vihti Viiala Viitasaari Viljakkala Vilppula Vimpeli Virolahti Virrat Vuolijoki Vårdö Vähäkyrö Värtsilä Västafjärd Vöyri Ylihärmä Yli-Ii Ylikiimiki Ylistaro Ylitorio Ylivieska Ylämaa Yläe Ylöjärvi Ypäjä Äetsä Ähtäri Ääekoski
23 Figure L1. The umber of total hip arthroplasties Figure L1. The umber of total hip betwee arthroplasties 1980 betwee Number of operatios Primary Revisio Year 24
24 Figure L2. Primary hip joit arthroplasties i me betwee i differet age groups Figure L2. Primary hip joit arthroplasties i me betwee i differet age groups Figure L3. Primary hip joit arthroplasties i wome betwee i differet age groups
25 Figure L4. Idicatios for primary total hip arthroplasties betwee Figure L4. Idicatios for primary total hip arthroplasties betwee Number of operatios Other arthritides Cogeital luxatio of the hip Rheumatoid arthritis Secodary osteoarthritis Other illess Primary osteoarthritis Year Figure L5. Complicatio rate i primary hip joit arthroplasties Figure L5. Complicatio rate betwee i primary 1995 hip joit arthroplasties betwee % 4,5 4,0 3,5 3,0 2,5 2,0 Woud ecrosis Aaesthetic complicatio Nerve ijury Death Haematoma Malpositio Thromboembolic complicatio Ifectio Luxatio Other primary complicatio 1,5 1,0 0,5 0, Year 26
26 Figure Figure L6. L6. The The average average legth legth of hospitalisatio of hospitalisatio due to edoprosthetic due to edoprosthetic surgery i hip surgery osteoarthritis, i hip me osteoarthritis, me (by cou (by courtesy of STAKES) STAKES) _49 50_59 60_69 70_79 80_89 Days Year Figure L7. Figure The average L7. The legth average of hospitalisatio legth of hospitalisatio due to edoprosthetic due to surgery edoprosthetic i hip osteoarthritis, surgery wome i hip osteoarthritis, wome (by courtesy of STAKES) courtesy of STAKES) _49 50_59 60_69 70_79 80_89 Days Year 27
27 Figure L8. Primary total hip joit arthroplasties i differet types of hospitals betwee Figure L8. Primary total hip joit arthroplasties i differet types of hospitals betwee % 70 % 60 % 50 % 40 % 30 % 20 % 10 % COXA Rheumatism Foudatio Hospital Orto Other Private Hospitals Uiversity Hospitals District Hospitals Cetral Hospitals 1995 N= N= N= N= N= N= N= N= N= N= % Figure L9. Total hip joit revisio arthroplasties i differet types of hospitals Figure L9. Total hip joit revisio arthroplasties i differet types of hospitals betwee betwee % 70 % 60 % 50 % 40 % 30 % 20 % 10 % COXA Rheumatism Foudatio Hospital Orto Other Private Hospitals Uiversity Hospitals District Hospitals Cetral Hospitals 1995 N= N= N= N= N= N= N= N= N= N= % Year 28
28 Figure L10. Total hip joit arthroplasties i primary osteoarthritis Figure L10. Total hip joit arthroplasties i primary osteoarthritis betwee betwee Note: Cofidece Note: iterval Cofidece refers iterval to refers ad is to very arrow ad is very arrow 85 % 80 % 75 % 70 % 65 % 80-87, N= , N= , N= % 55 % 50 % Year Figure Figure L11. L11. The use The of use cemeted of cemeted fixatio fixatio techique techique of prosthetic of prosthetic compoets compoets i primary total i primary hip arthroplasties total hip arthroplasties betwee betwee ,00 % 90,00 % 80,00 % Femoral compoet Acetabular compoet 70,00 % 60,00 % 50,00 % 40,00 % 30,00 % 20,00 % 10,00 % 0,00 %
29 Figure L12. Total hip joit edoprostheses i primary osteoarthritis betwee Figure L12. Total hip joit edoprostheses i primary osteoarthritis Cemeted / cemetless fixatio betwee Cemeted / cemetless fixatio 99 % 98 % Simplex tobramici, N=3433 Palacos getamici, N=9475 Cemetless, N= % 96 % 94 % 93 % 92 % 91 % Figure L13. Figure Atibiotic L13. prophylaxis Atibiotic i prophylaxis primary hip joit primary operatios hip betwee joit operatios betwee Proportio of atibiotics used 80 % 60 % 40 % 20 % Other atibiotics Cefotaxime/Ceftriaxoe Dicloxacilli/Cloxacilli Cefuroxime 0 % Year 30
30 Figure L14. Hip joit arthroplasty revisios i me durig i differet age groups Figure L15. L15. Hip Hip joit joit arthroplasty arthroplasty revisios revisios i wome i betwee wome betwee i differet age i groups differet age groups
31 Figure L16. Figure Idicatios L16. Idicatios for total hip for joit total arthroplasty hip joit revisios arthroplasty i 2004 revisios i Looseig (proximal compoet) Luxatio Looseig (distal compoet) Ifectio Looseig (both compoets) Fracture of boe Malpositio of prosthesis Fracture of prosthesis Other reaso Not kow Figure L17. Allograft ad autograft i hip joit revisios betwee Number of operatios Allograft Autograft Autograft+allograft 32
32 Figure L18. Figure Total L18. hip joit Total edoprostheses hip joit edoprostheses i primary i osteoarthritis, primary osteoarthritis, first revisio betwee first revisio betwee % 80 % 75 % 70 % 65 % 80-87, N= , N= , N= % 55 % 50 % Figure L19. Aual umber of hip joit revisio arthroplasties due to ifectio Figure L19. Aual umber of hip joit revisio arthroplasties due to ifectio Me Wome All Number Year 33
33 Figure L20. Time to revisio arthroplasty after the removal of the hip joit edoprosthesis Figure L20. Time to revisio arthroplasty after the removal of the hip joit edoprosthesis due to ifectio due to ifectio Mea with SD Media Days Year Figure L21. The proportio of the first, the secod ad the third total hip joit revisio Figure L21. The proportio of the first, the secod operatios ad the third i 2004 total hip joit revisio operatios i ,8 3, st revisio 2 d revisio 3 rd revisio Other 73,9 34
34 Table 3a. Primary hip joit arthroplasties i me with rheumatoid arthritis betwee Age TOTAL TOTAL Table 3b. Primary hip joit arthroplasties i wome with rheumatoid arthritis betwee Age TOTAL TOTAL
35 Figure L22. Total hip joit edoprostheses i rheumatoid arthritis Figure L22. Total hip joit edoprostheses betwee i rheumatoid arthritis betwee % 80 % 75 % 70 % 80-87, N= , N= , N= % 60 % 55 % 50 % Figure L23. Total hip joit edoprostheses i rheumatoid arthritis, Figure L23. Total hip joit edoprostheses i rheumatoid arthritis, first revisio betwee first revisio betwee % 80-87, N= , N= , N= % 75 % 70 % 65 % 60 % 55 % 50 %
36 Table 4. Total hip joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL STEM EXETER UNIVERSAL BIOMET COLLARLESS LUBINUS SP II SPECTRON EF ABG II BIRMINGHAM SUMMIT (DePuy) BASIS PRIMARY RESURFACING ASR C-STEM MATHYS CCM STD THOMPSON BIOM INTEGRAL LATER STANMORE PCA MERIDIAN TIGE VECTRA INOX CPT (ZIMMER) L-CORAIL (DePuy) RECAP (BIOMET) EMERAUDE BIOMET MALLORY/HEAD PRIMARY/LATERALIS CORMET RESURFACING SPOTORNO BIOMET B.FX ELITE PLUS FLANGED LPP II SYNERGY BIOM INTEGRAL P/R
37 Cotiued Table 4. Total hip joit edoprostheses i primary arthroplasties betwee I follow-up Deceased Revised Implated FEMORAL STEM BIOMET COLLARED BIOMET HEAD-NEC BIOMET CDH VERSYS (ZIMMER) MS-30 (KIRFIX) ELITE PL HIGH OFF S-ROM (S) BICONTACT BICONTACT semetillä BIOMET MALLORY/HEAD MODULAR OMNIFIT SYMAX BIOMET DYSPLASTIC ELITE PL ROUNDBACK ZMR (ZIMMER) OMNIFIT HA BICONTACT S CONELOCK REVISIO S-ROM REVISIO LINK REKONSTRUK LINK SATULAPROTEESI BIOMET INTERLOC STANMORE METS BIOMET BIHAPRO RESTORATION MODULAR ETM TRAUMASTEM (EXETER) ELITE PLUS REVISIO L-LINK C.F.P VECTRA 3 STD BIOMET MALLORY/HEAD REVISIO
38 Cotiued I follow-up Deceased Revised Implated Table 4. Total hip joit edoprostheses i primary arthroplasties betwee FEMORAL STEM ABG HA REEF (DePuy) BIOMET CUSTOM CDH DUROM RESURFACING AUSTIN-MOORE LUBINUS DEMI TUUMORIPROTEESI BRUNSWIK CHARNLEY CHARNLEY KERBOUL ELITE PLUS CDH LUBINUS IP LUBINUS SP I LINK RS EXETER MINNEAPOLIS LORD MADREPORIQ LORD L.F.R CERAVER (S) CERAVER REVISIO MÜLLER MONOLOG MÜLLER LATERAL MÜLLER STRAIGHT MÜLLER SLS, TIT MÜLLER SLS, MON VECTRA 2 STD VECTRA 3 LATER VECTRA 2 LATER VIRTEC STD
39 Cotiued Table 4. Total hip joit edoprostheses i primary arthroplasties betwee I follow-up Deceased Revised Implated FEMORAL STEM VIRTEC LATER TIGE VECTRA INOX LATERALISOIVA FURLONG BIAS REVISIO HARRIS-PRECOAT ANATOMIC MESH ZIM-MÜLL ZIMTRON LCO MCKEE RISKA BUTELL CF CENATOR PROXILOC PCA STANDARD PCA MEDIUM STEM PCA LONG STEM PCA E-SERIES PCA REVISIO PCA TEXTURED PCA HNR-PC BIOMET SHP BIOMET TAPERLOC BIOMET REACH/MALLORY/HEAD BICHAT ABG (S) ABG HA REVISIO WAGNER REVISIO OMNIFIT SEMENTOITAVA OMNIFIT HA
40 Cotiued I follow-up Deceased Revised Implated Table 4. Total hip joit edoprostheses i primary arthroplasties betwee FEMORAL STEM OMNIFIT RESTORATION OMNIFIT LONG HOWM RESTORATION T OMNIFIT HA MATHYS RM ISOELAS MATHYS RM HA BIOMET LMT BICONTACT SD EURO (S) V-PMB V-POROPOS LPP DIMENSION SF SUPERFINITOR SKT SUPERKONITAN PROFILE POROUS FREEMAN CALCAR MECRON UNI-HIP AML SHP LINK CORAIL MECROBLOCK FREEMAN
41 Cotiued Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs I follow-up Deceased Revised Implated FEMORAL STEM ACETABULUM EXETER UNIVERSAL CONTEMPORARY SPECTRON EF REFLECTION ALL POLY ABG II ABG II BIRMINGHAM BIRMINGHAM BIOMET COLLARLESS BIOMET VISION BIOMET COLLARLESS BIOMET ONE-PIECE CUP EXETER UNIVERSAL EXETER ALL POLY SUMMIT (DePuy) PINNACLE LUBINUS SP II LUBINUS STD LUBINUS SP II LUBINUS FC LUBINUS SP II LUBINUS ECCENTRIC ABG II OMNIFIT TRIDENT RESURFACING ASR RESURFACING ASR BIOMET COLLARLESS BIOMET EXCEED HAP BIOMET COLLARLESS STANMORE EXETER UNIVERSAL OMNIFIT TRIDENT EXETER UNIVERSAL ABG II SUMMIT (DePuy) PROFILE DURALOC BIOMET COLLARLESS M2A 38 FLARED ACET CUP PCA MERIDIAN PCA VITALOCK STANMORE BIOMET APOLY(S) C-STEM ELITE PLUS LPW EXETER UNIVERSAL PCA VITALOCK BIOM INTEGRAL LATER BIOMET ONE-PIECE CUP C-STEM ELITE PLUS OGEE SPECTRON EF REFLECTION INTERFIT MATHYS CCM STD MATHYS RM HA CPT (ZIMMER) TRILOGY
42 Cotiued Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs I follow-up Deceased Revised Implated FEMORAL STEM ACETABULUM L-CORAIL (DePuy) ELITE PLUS LPW RECAP (BIOMET) RECAP (BIOMET) BIOMET COLLARLESS BIOMET APOLY(S) CORMET RESURFACING CORMET RESURFACING EXETER UNIVERSAL ZIMMER MONOBLOCK BIOMET COLLARLESS BIOMET PFU TIGE VECTRA INOX MATHYS RM HA EXETER UNIVERSAL OSTEONICS UHR BIPOLAR SPOTORNO METASUL PRESS-FIT MATHYS CCM STD METASUL PRESS-FIT BIOMET COLLARLESS HEDROCEL BIOMET COLLARLESS TRILOGY EXETER UNIVERSAL BIOMET VISION SYNERGY BIRMINGHAM EMERAUDE WEBER METASUL BIOMET ONE-PIECE CUP BIOMET MALLORY/HEAD PRIMARY/ LATERALIS EMERAUDE WEBER PE CUP EXETER UNIVERSAL PROFILE DURALOC BIOMET COLLARLESS REFLECTION ALL POLY SPECTRON EF ZIMMER MONOBLOCK LUBINUS SP II LUBINUS VARIO-CUP MATHYS CCM STD MATHYS METAL-METAL EXETER UNIVERSAL HOWMED DOUBLE CUP VERSYS (ZIMMER) TRILOGY ABG II CONTEMPORARY BIOM INTEGRAL LATER STANMORE TIGE VECTRA INOX BIOMET PFU ELITE PLUS FLANGED ELITE PLUS LPW
43 Cotiued Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs I follow-up Deceased Revised Implated FEMORAL STEM ACETABULUM BIOMET HEAD-NEC BIOMET VISION MS-30 (KIRFIX) METASUL PRESS-FIT BIOM INTEGRAL P/R BIOMET VISION SUMMIT (DePuy) BIRMINGHAM SUMMIT (DePuy) RESURFACING ASR ELITE PLUS FLANGED ELITE PLUS OGEE EXETER UNIVERSAL BIOMEX ELITE PL HIGH OFF ELITE PLUS OGEE STANMORE STANMORE BIOM INTEGRAL LATER BIOMET VISION BIOMET CDH BIOMET VISION BIOMET COLLARLESS CONTEMPORARY LPP II LPP BIPOLAARI LPP II LPP MYLLERTYYPPI BIOMET PFU BIOMET MALLORY/HEAD PRIMARY/ LATERALIS BICONTACT BICONTACT PLASMA CUP STANMORE BIOMET VISION S-ROM (S) PINNACLE BICONTACT semetillä BICONTACT (S) BIOMET COLLARED STANMORE EXETER UNIVERSAL TRILOGY LUBINUS SP II CONTEMPORARY CPT (ZIMMER) ZIMMER ZCA LPP II LPP 10AST. KOROTUS BIOM INTEGRAL LATER BIOMET PFU BIOMET HEAD-NEC BIOMET ONE-PIECE CUP SPECTRON EF BIOMET VISION OMNIFIT HA OMNIFIT TRIDENT
44 Cotiued I follow-up Deceased Revised Implated Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs FEMORAL STEM ACETABULUM LUBINUS SP II BIOMET VISION BIOMET COLLARLESS EXETER ALL POLY BIOMET COLLARED BIOMET VISION BIOMET DYSPLASTIC BIOMET VISION BIOM INTEGRAL LATER BIOMET EXCEED HAP BIOMET INTERLOC BIOMET MÜLLER BIOMET COLLARLESS BIOMEX BIOMET COLLARLESS BIOMET MÜLLER ELITE PL ROUNDBACK ELITE PLUS LPW ELITE PL ROUNDBACK ELITE PLUS OGEE BIOMET COLLARLESS LUBINUS STD BIOMET CDH BIOMET PFU EXETER UNIVERSAL HEDROCEL CONELOCK REVISIO MATHYS RM HA BIOMET COLLARLESS PCA VITALOCK BICONTACT BICONTACT BIOMET COLLARLESS BIOMET BIPOLAR VECTRA 3 STD MÜLLER STD BIOMET COLLARLESS LUBINUS ECCENTRIC ABG HA ABG II ELITE PLUS FLANGED PROFILE DURALOC EXETER UNIVERSAL HGP II BIOMET COLLARLESS BIOMET MALLORY VECTRA 3 STD MATHYS RM HA BIOMET COLLARED BIOMET PFU OMNIFIT HA OMNIFIT SECUR-FIT BIOMET COLLARED TRILOGY ABG HA ABG HA MÜLLER SLS, MON MATHYS RM HA
45 Cotiued I follow-up Deceased Revised Implated Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs FEMORAL STEM ACETABULUM OMNIFIT HA OMNIFIT PSL HA LUBINUS SP II BIOMET PFU EXETER UNIVERSAL PCA CENTRAX EXETER UNIVERSAL ELITE PLUS OGEE MÜLLER MONOLOG MÜLLER STD BIOMET COLLARED BIOMET SHP MÜLLER SLS, TIT MÜLLER STD MÜLLER STRAIGHT MÜLLER STD BIOMET COLLARLESS PROFILE DURALOC BIOMET COLLARED HGP II BIOMET COLLARLESS ABG II BIOMET DYSPLASTIC BIOMET PFU LPP 3V-PMB (S) ABG (S) ABG (S) PCA E-SERIES PCA CLUSTER VECTRA 3 STD WAGNER STD AML PROFILE DURALOC ANATOMIC MESH HGP II BIOMET SHP BIOMET SHP BIOMET HEAD-NEC BIOMET PFU ABG HA PCA VITALOCK PROFILE POROUS PROFILE DURALOC PROXILOC HEDROCEL ELITE PL HIGH OFF ELITE PLUS LPW EXETER UNIVERSAL CHARNLEY HASTINGS BIOMET COLLARLESS HGP II MÜLLER SLS, MON MÜLLER SL TI LUBINUS SP II BIOMET MÜLLER ABG HA CONTEMPORARY
46 Cotiued I follow-up Deceased Revised Implated Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs FEMORAL STEM ACETABULUM BIOMET COLLARLESS BIOMET ROMANUS CHARNLEY CHARNLEY LPW OMNIFIT HA OMNIFIT PSL HA EXETER UNIVERSAL BIOMET PFU VECTRA 2 STD MATHYS RM HA ABG HA TRILOGY VECTRA 3 LATER MATHYS RM HA LUBINUS SP II OMNIFIT PSL HA CERAVER (S) CERAVER CERAMIC ELITE PL ROUNDBACK PROFILE DURALOC ANATOMIC MESH TRILOGY LUBINUS SP II BIOMET BIPOLAR BIOMET HEAD-NEC TRILOGY ELITE PL HIGH OFF PROFILE DURALOC SPOTORNO SPOTORNO EXPANS LUBINUS IP LUBINUS ECCENTRIC ELITE PLUS FLANGED HGP II LPP BIOMET BIPOLAR LUBINUS SP II ABG (S) CF-30 WEBER METASUL VECTRA 2 STD MÜLLER SL TI ABG HA HOWMED DOUBLE CUP MÜLLER SLS, TIT MATHYS RM HA LUBINUS SP II OMNIFIT SECUR-FIT ABG (S) CONTEMPORARY PCA E-SERIES PCA PEGGED BICONTACT semetillä LUBINUS ECCENTRIC BIOMET INTERLOC BIOMET PFU VECTRA 2 LATER MATHYS RM HA
47 Cotiued I follow-up Deceased Revised Implated Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs FEMORAL STEM ACETABULUM BIOMET COLLARLESS PCA PEGGED MECROBLOCK PROFILE DURALOC MÜLLER SLS, TIT MÜLLER SL TI ELITE PLUS FLANGED REFLECTION ALL POLY VECTRA 3 LATER WAGNER STD LCO HGP II BIOM INTEGRAL LATER HEDROCEL MÜLLER SLS, MON MÜLLER STD VECTRA 3 STD METASUL PRESS-FIT BIOMET COLLARLESS MATHYS RM HA LUBINUS SP II ABG II ZIM-MÜLL ZIMTRON HGP II BIOM INTEGRAL LATER TRILOGY BIOMET COLLARED BIOMET ROMANUS BIOMET COLLARED HOWMED DOUBLE CUP BIOMET COLLARED BIOMET MALLORY BIOMET COLLARLESS HEDROCEL REV ABG (S) BIOMET MÜLLER ANATOMIC MESH MÜLLER STD BIOMET INTERLOC BIOMET SHP ELITE PLUS FLANGED BIOMET PFU LUBINUS SP II MÜLLER BIPOLAR S-ROM REVISIO S-ROM POROUS BIOMET COLLARLESS ABG HA STANMORE BIOMET EXCEED HAP BIOMET COLLARLESS CHARNLEY HASTINGS BIOMET INTERLOC KIRSCHNER BIPOL LUBINUS SP I LUBINUS ECCENTRIC LUBINUS SP II BIOMET SHP
48 Cotiued I follow-up Deceased Revised Implated Table 5. Total hip joit edoprostheses i primary arthroplasties betwee , more tha 100 slidig pairs FEMORAL STEM ACETABULUM LUBINUS SP II PCA VITALOCK BIOMET HEAD-NEC HGP II ELITE PLUS FLANGED BIOMET SHP EXETER UNIVERSAL ABG HA VECTRA 2 STD MÜLLER STD ABG HA LUBINUS ECCENTRIC BIOMET COLLARLESS PCA CENTRAX BIOMET HEAD-NEC BIOMEX BIOMET HEAD-NEC HOWMED DOUBLE CUP ELITE PLUS FLANGED CHARNLEY HASTINGS MS-30 (KIRFIX) WEBER PE CUP ABG (S) HOWMED DOUBLE CUP BIOMET COLLARLESS BIOMET SHP ELITE PLUS CDH ELITE PLUS LPW ELITE PLUS FLANGED ABG II ELITE PLUS FLANGED BIOMET BIPOLAR LUBINUS SP II HGP II OMNIFIT HA LUBINUS ECCENTRIC PCA E-SERIES ELITE PLUS LPW PROFILE POROUS HGP II S-ROM (S) S-ROM POROUS
49 Figure Figure L24a. L24a. EXETER EXETER UNIVERSAL+ UNIVERSAL+ ABG II cup ABG hip II prosthesis cup hip prosthesis i primary i operatios primary operatios betwee betwee Me Wome Number of operatios Age Figure L24b. EXETER UNIVERSAL+ ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee Me 99 % 98 % 97 % Primary osteoarthritis, me =16085 Exeter Uiversal + ABG II = % 94 % 93 % 92 % 91 %
50 Figure L24c. EXETER UNIVERSAL+ ABG II cup hip prosthesis i primary osteoarthritis betwee Wome 99 % 98 % Primary osteoarthritis, wome =21849 Exeter Uiversal + ABG II = % 96 % 94 % 93 % 92 % 91 %
51 Figure L25a. EXETER UNIVERSAL + CONTEMPORARY cup hip edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure L25b. EXETER UNIVERSAL + CONTEMPORARY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, me N=16085 Exeter Uiversal + Cotemporary N= % 92 % 91 %
52 Figure L25c. EXETER UNIVERSAL+ CONTEMPORARY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, wome =21849 Exeter Uiversal+ Cotemporary = % 92 % 91 % Figure L25e. EXETER UNIVERSAL + CONTEMPORARY cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Rheumatoid arthritis, wome =2098 Exeter Uiversal + Cotemporary = % 92 % 91 %
53 Figure L26a. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome 1200 Number of operatios Age Figure L26b. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me N=16085 Exeter Uiversal+ Exeter All Poly N= % 94 % 93 % 92 % 91 %
54 Figure L26c. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, wome =21849 Exeter Uiversal+ Exeter All Poly = % 92 % 91 % Figure L26e. EXETER UNIVERSAL + EXETER ALL POLY cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Rheumatoid arthritis, wome =2098 Exeter Uiversal+ Exeter All Poly = % 92 % 91 %
55 Figure L27a. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure L27b. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, me =13040 Biomet Collarless+ Biomet Visio = % 92 % 91 %
56 Figure L27c. BIOMET COLLARLESS + BIOMET VISION cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, wome =17518 Biomet Collarless+ Biomet Visio = % 92 % 91 %
57 Figure L28a. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure L28b. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, me =16085 Lubius SP II+ Lubius Eccetric = % 92 % 91 %
58 Figure L28c. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritiss, wome =21849 Lubius SP II+ Lubius Eccetric = % 92 % 91 % Figure L28e. LUBINUS SP II+ LUBINUS ECCENTRIC cup hip joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Rheumatoid arthritis, wome =2098 Lubius SP II+ Lubius Eccetric = % 92 % 91 %
59 Figure L29a. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome 200 Number of operatios Age Figure L29b. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary osteoarthritis betwee Me 99 % 98 % Primary osteoarthritis, me =10020 Lubius SP II+ Lubius FC = % 96 % 94 % 93 % 92 % 91 %
60 Figure L29c. LUBINUS SP II+ LUBINUS FC cup hip joit edoprosthesis i primary osteoarthritis betwee Wome 99 % 98 % Primary osteoarthritis, wome =13127 Lubius SP II+ Lubius FC = % 96 % 94 % 93 % 92 % 91 %
61 Figure L30a. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure L30b. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis Figure L30b. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary osteoarthritis betwee i primary osteoarthritis betwee Me Me 99 % 98 % 97 % 96 % Primary osteoarthritis, me =16085 Lubius SP II+ Lubius STD = % 93 % 92 % 91 %
62 Figure L30c. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i primary osteoarthritis betwee Wome 99 % 98 % 97 % Primary osteoarthritis, wome =21849 Lubius SP II+ Lubius STD = % 94 % 93 % 92 % 91 % Figure L30e. LUBINUS SP II+ LUBINUS STD cup hip joit edoprosthesis i rheumatoid arthritis betwee Wome 99 % 98 % 97 % Rheumatoid arthritis, wome =2098 Lubius SP II+ Lubius STD = % 94 % 93 % 92 % 91 %
63 Figure L31a. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary arthroplasties betwee Number of operatios Me Wome Age Figure L31b. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % 96 % 94 % 93 % Primary osteoarthritis, me =11575 Spectro EF + Reflectio All Poly = % 91 %
64 Figure L31c. SPECTRON EF + REFLECTION ALL POLY cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, wome =15314 Spectro EF + Reflectio All Poly = % 92 % 91 %
65 Figure L32a. ABG II + ABG II cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome 400 Number of operatios Age Figure L32b. ABG II + ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % Primary osteoarthritis, me =11575 ABG II + ABG II = % 96 % 94 % 93 % 92 % 91 %
66 Figure L32c. ABG II + ABG II cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % Primary osteoarthritis, wome =15314 ABG II + ABG II = % 93 % 92 % 91 %
67 Figure L33a. BIRMINGHAM + BIRMINGHAM cup hip joit edoprosthesis i primary arthroplasties betwee Me Wome 400 Number of operatios Age Figure L33b. BIRMINGHAM+ BIRMINGHAM cup hip joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =8290 Birmigham + Birmigham = % 94 % 93 % 92 % 91 %
68 Figure L33c. BIRMINGHAM+ BIRMINGHAM cup hip joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % 93 % Primary osteoarthritis, wome =10838 Birmigham + Birmigham = % 91 %
69 Figure P1. Primary ad revisio total kee joit arthroplasties Figure P1. Primary ad revisio total kee joit arthroplasties betwee betwee Primary Revisio Number of operatios Year 70
70 Figure P2. Primary kee arthroplasties i differet age groups i me betwee Figure P3. Primary kee arthroplasties i differet age groups i wome betwee
71 Figure P4. Primary idicatios for total kee joit arthroplasties betwee Other arthritides Rheumatoid arthritis Number of operatios Secodary osteoarthritis Other illess Primary osteoarthritis Year Figure Figure P5. Complicatio P5. Complicatio rate i rate primary i primary kee joit kee arthroplasties joit arthroplasties betwee betwee % 5,0 4,5 4,0 3,5 3,0 2,5 2,0 Woud ecrosis Aaesthetic complicatio Nerve ijury Death Haematoma Malpositio Thromboembolic complicatio Ifectio Luxatio Other primary complicatio 1,5 1,0 0,5 0,
72 Figure Figure P6. The P6. average The average legth of hospitalisatio legth of hospitalisatio due to edoprosthetic due to surgery edoprosthetic i kee osteoarthritis, surgery me i kee osteoarthritis, m (by courtesy of STAKES) of STAKES) 14 Days _49 50_59 60_69 70_79 80_ Year Figure P7. The average legth of hospitalisatio due to edoprosthetic surgery i kee osteoarthritis, wome Figure P7. The average legth of hospitalisatio due to edoprosthetic surgery i kee osteoarthritis, wom (by courtesy of STAKES) courtesy of STAKES) _49 50_59 60_69 70_79 80_89 8 Days Year 73
73 Figure P8. Primary total kee joit arthroplasties i differet types of hospitals betwee Figure P8. Primary total kee joit arthroplasties i differet types of hospitals betwee % 70 % 60 % 50 % 40 % 30 % 20 % 10 % COXA Rheumatism Foudatio Hospital Orto Other Private Hospitals Uiversity Hospitals District Hospitals Cetral Hospitals 1995 N= N= N= N= N= N= N= N= N= N= % Figure P9. Total Figure kee joit P9. Total revisio kee arthroplasties joit revisio i differet arthroplasties types of hospitals i differet betwee types 1995 of - hospitals 2004 betwee % 70 % 60 % 50 % 40 % 30 % 20 % 10 % COXA Rheumatism Foudatio Hospital Orto Other Private Hospitals Uiversity Hospitals District Hospitals Cetral Hospitals 1995 N= N= N= N= N= N= N= N= N= N=582 0 % Year 74
74 Figure P10. Total kee edoprostheses i primary osteoarthritis betwee Note: Cofidece iterval refers to ad is very arrow 85 % 80-87, = , = , = % 75 % 70 % 65 % 60 % 55 % 50 % Figure P11. P11. The The use use of cemeted of cemeted fixatio fixatio techique techique of prosthetic of prosthetic compoets compoets i primary kee i arthroplasties primary kee arthroplasties betw betwee ,00 % 90,00 % Femoral compoet Tibial compoet 80,00 % 70,00 % 60,00 % 50,00 % 40,00 % 30,00 % 20,00 % 10,00 % 0,00 %
75 Figure P12. Kee edoprostheses i primary osteoarthritis betwee Cemeted / cemetless fixatio 99 % 98 % 97 % Simplex tobramici, =6593 Palacos getamici, =25145 Cemetless, = % 94 % 93 % 92 % 91 % Figure P13. Atibiotic prophylaxis i pimary kee arthroplasties betwee Proportio of atibiotics used 80 % 70 % 60 % 50 % 40 % 30 % Other atibiotics Cefotaxime/Ceftriaxoe Dicloxacilli/Cloxacilli Cefuroxime 20 % 10 % 0 % Operatio year 76
76 Figure P14. Kee arthroplasty revisios i differet age groups i me betwee Figure P15. Kee arthroplasty revisios i differet age groups i wome betwee
77 Figure P16. Idicatios for total kee joit arthroplasty revisios i 2004 Figure P16. Idicatios for total kee joit arthroplasty revisios i Ifectio Malpositio of prosthesis Patellar complicatio Looseig (distal compoet) Looseig (both compoets) Fracture of boe Luxatio Fracture of prosthesis Looseig (proximal compoet) Other reaso Not kow Figure P17. Allograft ad autograft i kee revisios betwee Number of operatios Allograft Autograft Autograft+allograft 78
78 Figure P18. Total kee joit edoprostheses i primary osteoarthritis, first revisio betwee % 80-87, = , = , = % 75 % 70 % 65 % 60 % 55 % 50 % Figure P19. The proportio of the first, the secod ad the third total kee joit revisio operatios i ,3 1,4 18,7 1 st revisio 2 d revisio 3 rd revisio Other 75,6 79
79 Table 6a. Primary kee arthroplasties i me with rheumatoid arthritis betwee Age TOTAL TOTAL Table 6b. Primary kee arthroplasties i wome with rheumatoid arthritis betwee Age TOTAL TOTAL
80 Figure P20. Total kee joit edoprostheses i rheumatoid arthritis betwee % 80-87, = , = , = % 75 % 70 % 65 % 60 % 55 % 50 % Figure P21. Total kee joit edoprostheses i rheumatoid arthritis, first revisio betwee % 88-95, = , = % 75 % 70 % 65 % 60 % 55 % 50 %
81 Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL COMPONENT DURACON AGC V P.F.C SIGMA P.F.C SIGMA STAB NEXGEN LPS OXFORD UNICOMPARTMENTAL PHASE MAXIM PRIMARY ARGE NEXGEN CR DURACON STABILIZER BOX DURACON/MODULAR TS MAXIM PS SEARCH EVOLUTION AGC V2 STAB P.F.C SIGMA TC DURACON ISA NEXGEN LCCK ENDO MODELL-LINK PRESERVATION UNI KNEE AGC DUAL ARTICULAR NEXGEN Rotatig Hige GENESIS II DURACON/ROTATING HINGE AGC DUAL ARTICULAR NEXGEN LPS FLEX MOBILE MAXIM CONSTRAINED MILLER-G/UNICOND
82 Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL COMPONENT FINN-KNEE CUSTOM S-ROM ARGE STABILOITU KINEMAX ROTATING HINGE HMRS ROTATING HINGE GUEPAR (HINGED) ST.GEORG TOWNLEY MARMOR FREEMAN-SAMUELS KINEMATIC STAB RICHARDS ENDO MODELL-SC PCA AMK AMK STAB PCA/MODULAR PCA/INTERAX PCA/REVISIO PCA-INTERAX DI LINK T.A.C.K ORTHOMET FREEMAN-SWANSS DURACON/DEMI ROTAGLIDE/CORIN NATURAL-KNEE KINEMATIC ROTATING HINGE R.BRIGHAM/UNICONDY
83 Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL COMPONENT SEARCH MBK (ZIMMER) GENESIS I S+G (ORTHOPLANT) GSP/ALLOPRO SYNATOMIC TOWNLEY SYNATOMIC+DOME P.F.C PRESS FITT P.F.C STAB P.F.C TC TRICON PCA/UNICONDYLAR KINEMATIC MILLER-G I AGC TC IV SYNATOMIC LCS-PORO (DEPUY) PERFORMANCE PERFORMANCE STABILOITU OXFORD MENISCEAL PHASE II MILLER-G I/PRECOAT KIRSCNER/UNICOND ORTHOPLANT I ROTA-FLEX II MILLER-G II AMK/CORDINATE TUUMORIPROTEESI
84 Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL COMPONENT MÜLLER SLS, MON VECTRA 2 STD VECTRA 3 LATER VECTRA 2 LATER VIRTEC STD VIRTEC LATER TIGE VECTRA INOX LATERALISOIVA FURLONG BIAS REVISIO HARRIS-PRECOAT ANATOMIC MESH ZIM-MÜLL ZIMTRON LCO MCKEE RISKA BUTELL CF CENATOR PROXILOC PCA STANDARD PCA MEDIUM STEM PCA LONG STEM PCA E-SERIES PCA REVISIO PCA TEXTURED PCA HNR-PC BIOMET SHP BIOMET TAPERLOC BIOMET REACH/MALLORY/HEAD BICHAT
85 Table 7. Total kee joit edoprostheses i primary arthroplasties betwee Cotiued I follow-up Deceased Revised Implated FEMORAL COMPONENT ABG (S) WAGNER REVISIO OMNIFIT SEMENTOITAVA OMNIFIT HA OMNIFIT RESTORATION OMNIFIT LONG HOWM RESTORATION T OMNIFIT HA MATHYS RM ISOELAS MATHYS RM HA BIOMET LMT BICONTACT SD EURO (S) V-PMB V-POROPOS LPP DIMENSION SF SUPERFINITOR SKT SUPERKONITAN PROFILE POROUS FREEMAN CALCAR MECRON UNI-HIP AML SHP LINK CORAIL MECROBLOCK FREEMAN
86 Figure P22a. DURACON kee edoprosthesis i primary arthroplasties Figure P22a. DURACON kee edoprosthesis betwee i primary arthroplasties betwee Me Wome Number of operatios Age Figure P22b. DURACON kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =11578 DURACON = % 94 % 93 % 92 % 91 %
87 Figure P22c. DURACON kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % Primary osteoarthritis, wome =30039 DURACON = % 96 % 94 % 93 % 92 % 91 % Figure P22d. DURACON kee joit edoprosthesis i rheumatoid arthritis betwee , Me 99 % 98 % Rheumatoid arthritis, me =704 DURACON = % 96 % 94 % 93 % 92 % 91 %
88 Figure P22e. DURACON kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Rheumatoid arthritis,wome =2947 DURACON = % 92 % 91 %
89 Figure P23a. AGC V2 kee joit edoprosthesis i primary arthroplasties betwee Me Wome 3000 Number of operatios Age Figure P23b. AGC V2 kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =11578 AGC V2 = % 94 % 93 % 92 % 91 %
90 Figure P23c. AGC V2 kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % Primary osteoarthritis, wome =30039 AGC V2 = % 96 % 94 % 93 % 92 % 91 % Figure P23d. AGC V2 kee joit edoprosthesis i rheumatoid arthritis betwee , Me 99 % 98 % Rheumatoid arthritis, me =704 AGC V2 = % 96 % 94 % 93 % 92 % 91 %
91 Figure P23e. AGC V2 kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % Rheumatoid arthritis, wome =2947 AGC V2 = % 96 % 94 % 93 % 92 % 91 %
92 Figure P24a. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary arthroplasties betwee Me Wome 200 Number of operatios Age Figure P24b. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % Primary osteoarthritis, me =10863 AGC V2+MAXIM = % 96 % 94 % 93 % 92 % 91 %
93 Figure P24c. AGC V2 + MAXIM tibia kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % Primary osteoarthritis, wome =27557 AGC V2 + MAXIM = % 96 % 94 % 93 % 92 % 91 %
94 Figure P25a. P.F.C SIGMA kee joit edoprosthesis i primary arthroplasties betwee Me Wome 1600 Number of operatios Age Figure P25b. P.F.C SIGMA kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % Primary osteoarthritis, me =9970 P.F.C SIGMA = % 96 % 94 % 93 % 92 % 91 %
95 Figure P25c. P.F.C SIGMA kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % Primary osteoarthritis, wome =24790 P.F.C SIGMA = % 96 % 94 % 93 % 92 % 91 % Figure P25e. P.F.C SIGMA kee joit edoprosthesis i rheumatoid arthritis betwee , Wome 99 % 98 % 97 % Rheumatoid arthritis, wome =2282 P.F.C.SIGMA = % 94 % 93 % 92 % 91 %
96 Figure P26a. P.F.C SIGMA STAB kee joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure P26b. P.F.C SIGMA STAB kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % 96 % 94 % 93 % Primary osteoarthritis, me =9970 P.F.C SIGMA STAB = % 91 %
97 Figure P26c. P.F.C SIGMA STAB kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % Primary osteoarthritis, wome =24790 P.F.C SIGMA STAB = % 92 % 91 %
98 Figure P27a. NEXGEN LPS kee joit edoprosthesis i primary arthroplasties betwee Me Wome 800 Number of operatios Age Figure P27b. NEXGEN LPS kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % Primary osteoarthritis, me =10863 NEXGEN LPS = % 96 % 94 % 93 % 92 % 91 %
99 Figure P27c. NEXGEN LPS kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % Primary osteoarthritis, wome =27557 NEXGEN LPS = % 94 % 93 % 92 % 91 %
100 Figure P28a. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure P28b. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =9087 OXFORD U = % 94 % 93 % 92 % 91 %
101 Figure P28c. OXFORD UNICOMPARTMENTAL kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % Primary osteoarthritis, wome =22072 OXFORD U = % 94 % 93 % 92 % 91 %
102 Figure P29a. MAXIM PRIMARY kee joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure P29b. MAXIM PRIMARY kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =9970 MAXIM PRIMARY = % 94 % 93 % 92 % 91 %
103 Figure P29c. MAXIM PRIMARY kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % Primary osteoarthritis, wome =24790 MAXIM PRIMARY = % 94 % 93 % 92 % 91 %
104 Figure P30a. ARGE kee joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure P30b. ARGE kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % Primary osteoarthritis, me =9970 ARGE = % 96 % 94 % 93 % 92 % 91 %
105 Figure P30c. ARGE kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % Primary osteoarthritis, wome =24790 ARGE = % 94 % 93 % 92 % 91 %
106 Figure P31a. NEXGEN CR kee joit edoprosthesis i primary arthroplasties betwee Me Wome Number of operatios Age Figure P31b. NEXGEN CR kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =11578 NEXGEN CR = % 94 % 93 % 92 % 91 %
107 Figure P31c. NEXGEN CR kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % Primary osteoarthritis, wome =30039 NEXGEN CR = % 94 % 93 % 92 % 91 %
108 Figure P32a. DURACON Stabilizer box kee joit edoprosthesis i primary arthroplasties betwee Me Wome 200 Number of operatios Age Figure P32b. DURACON stabilizer box kee joit edoprosthesis i primary osteoarthritis betwee , Me 99 % 98 % 97 % Primary osteoarthritis, me =11578 DURACON Stabilizer box = % 94 % 93 % 92 % 91 %
109 Figure P32c. DURACON Stabilizer box kee joit edoprosthesis i primary osteoarthritis betwee , Wome 99 % 98 % 97 % 96 % 94 % 93 % Primary osteoarthritis, wome =30039 DURACON Stabilizer box = % 91 %
110 Figure M1. Primary ad revisio arthroplasties of other joit operatios betwee Primary Revisio Number of operatios Year Figure M2. Primary arthroplasties of other joits i Shoulder Mcp 32 Akle Elbow Cmc Other costructio Ip Mtp 80 Femoropatellar joit oly Scaphoideum Luatum
111 Figure M3. Primary idicatios for arthroplasties of other joits betwee Number of operatios Other illess Other arthritides Rheumatoid arthritis Secodary osteoarthritis Primary osteoarthritis Year Figure M4. Shoulder prostheses i primary arthroplasties betwee % 96-04, = % 97 % 96 % 94 % 93 % 92 % 91 %
112 Figure M5. Akle prostheses i primary arthroplasties betwee % 98 % 96-04, = % 96 % 94 % 93 % 92 % 91 % Figure M6. Elbow prostheses i primary arthroplasties betwee % 98 % 96-04, = % 96 % 94 % 93 % 92 % 91 %
113 Figure M7. Idicatios for revisio arthroplasties of other joits i Fracture of prosthesis Not kow Looseig of prosthetic compoet Malpositio of prosthesis Luxatio Ifectio Fracture of boe Other reaso
114 ISSN ISBN ISBN Natioal Agecy for Medicies, P.O. Box 55, FI Helsiki, FINLAND Tel , fax Orders: [email protected]
Using AMI in SCADA-DMS for advanced network operation. Stefan Rebner/Fortum/ 2013-03-21
Using AMI in SCADA-DMS for advanced network operation Stefan Rebner/Fortum/ 2013-03-21 Stockholm, 2009-01-07 09:24 Fortum in short Nr 1 Nr 2 Poland Heat Heat sales Electricity sales Distribution Electricity
ASSISTIVE TECHNOLOGY DELIVERY SYSTEMS IN REHABILITATION - effectivity of delivery
Pohjois-Pohjanmaan sairaanhoitopiiri ASSISTIVE TECHNOLOGY DELIVERY SYSTEMS IN REHABILITATION - effectivity of delivery Eero Kyllönen M.D., Ph.D. Clinic of Physical and Rehabilitation Medicine Oulu University
CSFII Organizational Structure Sector IV-7-B
(HARRI ALA-KULJU) 36 / 3 District 17 E ( HEIDI RANTALA ) 82 / 1 Group IV-7-B-17 E-A (REIMA MÄKELÄ) 6 / TAMPERE 2573. TAMPERE AMURI 2574. TAMPERE KAAKINMAA 3214. TAMPERE CITY 4371. TAMPERE ITAVAYLA 48665.
Communal Heating Centers
Communal Heating Centers Heating Center Location (Finland) Boiler Output MW Delivery Fuel Södervik Energi Ab Ala- Veteli Grate combustion 1,2 2015 wood chip Pori Energia Oy, total output 5.0 MW Kristiinankaupunki
OULU UNIVERSITY HOSPITAL. P romoting better health
OULU UNIVERSITY HOSPITAL P romoting better health Top healthcare provider Oulu University Hospital (OYS) is an innovative, research and development-oriented provider of high-quality healthcare. The five
FINNISH-RUSSIAN SME WORKING GROUP MEETING 29.06.2007 Riihimäki
FINNISH-RUSSIAN SME WORKING GROUP MEETING 29.06.2007 Riihimäki Timo Puukko Business Analyst TE-Centre for Häme,Business Division www.te-keskus.fi Employment and Economic Development Centres 1. Uusimaa,
COMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 08.06.1995 COM(95) 236 final 95/0138 (CNS) Proposal for a COUNCIL DIRECTIVE concerning the Community list of less-favoured farming areas within the meaning
SECTION VII. Composting plants Article 24 of Regulation (EC) No 1069/2009 Approval number Name Town/Region Category Activities and Product types
FIC020-01706/2008NA Andelslaget Monäs Biokompost 66970 Uusikaarleby 2 FIC020-01709/2008NA Andelslaget Oravais Kompost 66820 Oravainen 2 FIC020-04841/2009NA Andelslaget Pensala Biocompost 66840 Pensala
Analyzing Longitudinal Data from Complex Surveys Using SUDAAN
Aalyzig Logitudial Data from Complex Surveys Usig SUDAAN Darryl Creel Statistics ad Epidemiology, RTI Iteratioal, 312 Trotter Farm Drive, Rockville, MD, 20850 Abstract SUDAAN: Software for the Statistical
THE EU ETS IN THE FINNISH CONTEXT Does the ETS support local bioenergy implementation?
THE EU ETS IN THE FINNISH CONTEXT Does the ETS support local bioenergy implementation? Pirkko Vesterinen, VTT IEA Task 38 & Task 4 Workshop, Trondheim 5-6 April 26 FUEL PRICES IN HEAT PRODUCTION Fuel chips
Timothy Laitila Vincent Finnish Genealogy Siirtolaisuusinstituutti Migrationsinstitutet Turku Åbo 2003
Timothy Laitila Vincent Finnish Genealogy Siirtolaisuusinstituutti Migrationsinstitutet Turku Åbo 2003 http://www.migrationinstitute.fi 2 Finnish Genealogy "Where do I begin?" The hundreds of thousands
Hypothesis testing. Null and alternative hypotheses
Hypothesis testig Aother importat use of samplig distributios is to test hypotheses about populatio parameters, e.g. mea, proportio, regressio coefficiets, etc. For example, it is possible to stipulate
Prescribing costs in primary care
Prescribig costs i primary care LONDON: The Statioery Office 13.50 Ordered by the House of Commos to be prited o 14 May 2007 REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 454 Sessio 2006-2007 18 May
Determining the sample size
Determiig the sample size Oe of the most commo questios ay statisticia gets asked is How large a sample size do I eed? Researchers are ofte surprised to fid out that the aswer depeds o a umber of factors
Effective transport connections for a thriving Finland
Effective transport connections for a thriving Finland A more efficient transport system The role of the FTA is to develop the road, railway and waterways networks into an integrated and efficient transport
PIRKANMAA POLYTECHNIC Tampere 16.4.2004 TAMPERE REGION. Ms. Elina Nirvi, Senior Officer in International Affairs Council of Tampere Region
PIRKANMAA POLYTECHNIC Tampere 16.4.2004 TAMPERE REGION Ms. Elina Nirvi, Senior Officer in International Affairs Council of Tampere Region Finland s Regions Population 31.12.2003 1 Uusimaa 1 338 180 2 Itä-Uusimaa
Confidence Intervals. CI for a population mean (σ is known and n > 30 or the variable is normally distributed in the.
Cofidece Itervals A cofidece iterval is a iterval whose purpose is to estimate a parameter (a umber that could, i theory, be calculated from the populatio, if measuremets were available for the whole populatio).
Evaluating Model for B2C E- commerce Enterprise Development Based on DEA
, pp.180-184 http://dx.doi.org/10.14257/astl.2014.53.39 Evaluatig Model for B2C E- commerce Eterprise Developmet Based o DEA Weli Geg, Jig Ta Computer ad iformatio egieerig Istitute, Harbi Uiversity of
References. Plastic industry
References Plastic industry PROFILE SILOS Buyer Pcs Size m Raw material Use Talmu Oy Pertteli, Finland 2, x, 8 painted steel sheet 2 2,5 x 2,5 40 painted steel sheet Ranimuovi Oy 2,0 x,9 2,0 x,9 29 painted
Enhancing Oracle Business Intelligence with cubus EV How users of Oracle BI on Essbase cubes can benefit from cubus outperform EV Analytics (cubus EV)
Ehacig Oracle Busiess Itelligece with cubus EV How users of Oracle BI o Essbase cubes ca beefit from cubus outperform EV Aalytics (cubus EV) CONTENT 01 cubus EV as a ehacemet to Oracle BI o Essbase 02
COMENIUS 2012 Monen oppilaitoksen väliset hankkeet
COMENIUS 2012 Monen oppilaitoksen väliset hankkeet Hankenumero Oppilaitos Paikkakunta Hankkeen nimi Tukisumma 1 2012 1 FI1 COM06 09555 1 Alajärven lukio Alajärvi Teach Together Learn Together 20000 2 2012
Siirtolaishistoria (Yleinen historia, Turun yliopisto): Palautetut kyselylomakkeet USA ja Kanada
Siirtolaishistoria (Yleinen historia, Turun yliopisto): Palautetut kyselylomakkeet USA ja Kanada N:o 1968 Lähettäjä Asuinpaikkakunta Lähtöpaikkakunta 1 30.7. Tilda Justinen Richmond Hill, N.Y. Hollola
Soving Recurrence Relations
Sovig Recurrece Relatios Part 1. Homogeeous liear 2d degree relatios with costat coefficiets. Cosider the recurrece relatio ( ) T () + at ( 1) + bt ( 2) = 0 This is called a homogeeous liear 2d degree
How to read A Mutual Fund shareholder report
Ivestor BulletI How to read A Mutual Fud shareholder report The SEC s Office of Ivestor Educatio ad Advocacy is issuig this Ivestor Bulleti to educate idividual ivestors about mutual fud shareholder reports.
1 Correlation and Regression Analysis
1 Correlatio ad Regressio Aalysis I this sectio we will be ivestigatig the relatioship betwee two cotiuous variable, such as height ad weight, the cocetratio of a ijected drug ad heart rate, or the cosumptio
Engineering Data Management
BaaERP 5.0c Maufacturig Egieerig Data Maagemet Module Procedure UP128A US Documetiformatio Documet Documet code : UP128A US Documet group : User Documetatio Documet title : Egieerig Data Maagemet Applicatio/Package
National Institute on Aging. What Is A Nursing Home?
Natioal Istitute o Agig AgePage Nursig Homes: Makig The Right Choice Lucille has lived i her home for 33 years. Eve after her husbad died 3 years ago, she was able to maage o her ow. Recetly, she broke
Lesson 15 ANOVA (analysis of variance)
Outlie Variability -betwee group variability -withi group variability -total variability -F-ratio Computatio -sums of squares (betwee/withi/total -degrees of freedom (betwee/withi/total -mea square (betwee/withi
Wind energy statistics in Finland 2013 Version: Public. [Photo: Taaleritahdas Oyj, Honkajoki wind plant]
Wind energy statistics in Finland 2013 Version: Public [Photo: Taaleritahdas Oyj, Honkajoki wind plant] Click Wind to energy edit Master year 2013 title style End of year capacity in Finland: 448MW (211
One-sample test of proportions
Oe-sample test of proportios The Settig: Idividuals i some populatio ca be classified ito oe of two categories. You wat to make iferece about the proportio i each category, so you draw a sample. Examples:
Planning for Your Hip Replacement Surgery
Plaig for Your Hip Replacemet Surgery About Our Uit Welcome to Sata Moica-UCLA Medical Ceter ad Orthopaedic Hospital ad thak you for puttig your trust i us for your hip surgery ad rehabilitatio. This brochure
ODBC. Getting Started With Sage Timberline Office ODBC
ODBC Gettig Started With Sage Timberlie Office ODBC NOTICE This documet ad the Sage Timberlie Office software may be used oly i accordace with the accompayig Sage Timberlie Office Ed User Licese Agreemet.
Amendments to employer debt Regulations
March 2008 Pesios Legal Alert Amedmets to employer debt Regulatios The Govermet has at last issued Regulatios which will amed the law as to employer debts uder s75 Pesios Act 1995. The amedig Regulatios
5: Introduction to Estimation
5: Itroductio to Estimatio Cotets Acroyms ad symbols... 1 Statistical iferece... Estimatig µ with cofidece... 3 Samplig distributio of the mea... 3 Cofidece Iterval for μ whe σ is kow before had... 4 Sample
OWERWIEW OF FINISH FOREST INDUSTRY Done by Kauko Konsult ja Invest
OWERWIEW OF FINISH FOREST INDUSTRY Done by Kauko Konsult ja Invest May 31.09 Veitsiluoto Mill K. Mikkonen Forests cover 60 % of the area in Finland Total area in Finland 33.8 mill. ha Built-up areas
Employment and Economic Development Centre for Uusimaa
Employment and Economic Development Centre for Uusimaa Maistraatinportti 2, P.O.Box 15, 00241 Helsinki tel. +358 10 60 21000, fax +358 10 60 21100 www.te-keskus.fi/uusimaa e-mail: [email protected]
Quality Indicators for Trauma Outcome and Performance
2010 The Trauma Audit & Research Network Quality Idicators for Trauma Outcome ad Performace The TRAUMA Audit & Research NETWORK DEVELOPING EFFECTIVE CARE FOR INJURED PATIENTS THROUGH PROCESS AND OUTCOME
*The most important feature of MRP as compared with ordinary inventory control analysis is its time phasing feature.
Itegrated Productio ad Ivetory Cotrol System MRP ad MRP II Framework of Maufacturig System Ivetory cotrol, productio schedulig, capacity plaig ad fiacial ad busiess decisios i a productio system are iterrelated.
Clinical drug trials from a university hospital's point of view. Aki Lindén, CEO, Helsinki University Hospital
Clinical drug trials from a university hospital's point of view Aki Lindén, CEO, Helsinki University Hospital National Responsibilities and Special Areas 2014 5 university hospital districts: HUCH - Helsinki
Predictive Modeling Data. in the ACT Electronic Student Record
Predictive Modelig Data i the ACT Electroic Studet Record overview Predictive Modelig Data Added to the ACT Electroic Studet Record With the release of studet records i September 2012, predictive modelig
Chapter 7 - Sampling Distributions. 1 Introduction. What is statistics? It consist of three major areas:
Chapter 7 - Samplig Distributios 1 Itroductio What is statistics? It cosist of three major areas: Data Collectio: samplig plas ad experimetal desigs Descriptive Statistics: umerical ad graphical summaries
Section 3: Renters and Rental Units
Sectio 3: Reters ad Retal Uits About two millio New York City households roughly two-thirds ret their homes. Over the past decade retal housig has become less affordable to may New Yorkers. Give the dowtur
Example 2 Find the square root of 0. The only square root of 0 is 0 (since 0 is not positive or negative, so those choices don t exist here).
BEGINNING ALGEBRA Roots ad Radicals (revised summer, 00 Olso) Packet to Supplemet the Curret Textbook - Part Review of Square Roots & Irratioals (This portio ca be ay time before Part ad should mostly
CHAPTER 7: Central Limit Theorem: CLT for Averages (Means)
CHAPTER 7: Cetral Limit Theorem: CLT for Averages (Meas) X = the umber obtaied whe rollig oe six sided die oce. If we roll a six sided die oce, the mea of the probability distributio is X P(X = x) Simulatio:
New job at the Japanese company, would like to know about the health insurance. What's the process to apply for the insurance?
Cabiet ねん かせんぶ ねん しゅが かせんぶ じてん しゅうせい 8-4-2 (2008 年 下 線 部 &2009 年 朱 書 き 下 線 部 時 点 修 正 ) Level 3 Chapter Illess Sectio Public health isurace Cotets Health isurace 1 Possible questio ad backgroud. New job
Center, Spread, and Shape in Inference: Claims, Caveats, and Insights
Ceter, Spread, ad Shape i Iferece: Claims, Caveats, ad Isights Dr. Nacy Pfeig (Uiversity of Pittsburgh) AMATYC November 2008 Prelimiary Activities 1. I would like to produce a iterval estimate for the
A GUIDE TO LEVEL 3 VALUE ADDED IN 2013 SCHOOL AND COLLEGE PERFORMANCE TABLES
A GUIDE TO LEVEL 3 VALUE ADDED IN 2013 SCHOOL AND COLLEGE PERFORMANCE TABLES Cotets Page No. Summary Iterpretig School ad College Value Added Scores 2 What is Value Added? 3 The Learer Achievemet Tracker
Wind energy statistics in Finland 2012 Public version. [Source: Tuuliwatti Oy (Simo wind plant)]
Wind energy statistics in Finland 2012 Public version [Source: Tuuliwatti Oy (Simo wind plant)] Click Wind to energy edit Master year 2012 title style Click End of to year edit capacity Master in text
Agency Relationship Optimizer
Decideware Developmet Agecy Relatioship Optimizer The Leadig Software Solutio for Cliet-Agecy Relatioship Maagemet supplier performace experts scorecards.deploymet.service decide ware Sa Fracisco Sydey
Railway simulation using OpenTrack in Finland
Railway simulation using OpenTrack in Finland Tero Kosonen VR-Track Ltd / Railway Consulting Contents: Overview of the Finnish railway scene All OpenTrack simulation studies done in Finland Previews of
Case Study. Normal and t Distributions. Density Plot. Normal Distributions
Case Study Normal ad t Distributios Bret Halo ad Bret Larget Departmet of Statistics Uiversity of Wiscosi Madiso October 11 13, 2011 Case Study Body temperature varies withi idividuals over time (it ca
1 Computing the Standard Deviation of Sample Means
Computig the Stadard Deviatio of Sample Meas Quality cotrol charts are based o sample meas ot o idividual values withi a sample. A sample is a group of items, which are cosidered all together for our aalysis.
Introducing Your New Wells Fargo Trust and Investment Statement. Your Account Information Simply Stated.
Itroducig Your New Wells Fargo Trust ad Ivestmet Statemet. Your Accout Iformatio Simply Stated. We are pleased to itroduce your ew easy-to-read statemet. It provides a overview of your accout ad a complete
Modified Line Search Method for Global Optimization
Modified Lie Search Method for Global Optimizatio Cria Grosa ad Ajith Abraham Ceter of Excellece for Quatifiable Quality of Service Norwegia Uiversity of Sciece ad Techology Trodheim, Norway {cria, ajith}@q2s.tu.o
Professional Networking
Professioal Networkig 1. Lear from people who ve bee where you are. Oe of your best resources for etworkig is alumi from your school. They ve take the classes you have take, they have bee o the job market
National training survey 2014
Natioal traiig survey 2014 Key fidigs NATIONAL TRAINING SURVEY Joi us o #GMCsurvey Itroductio Every year, we ask aroud 54,000 doctors i postgraduate traiig what they thik about the quality of their traiig.
DEFENCE FORCES REFORM CONCEPT
DEFENCE FORCES REFORM CONCEPT Press Conference at the Government Palace 8 February 2012 Commander of the 7 February 2012 1 Autumn 2010 Defence Forces Reform - Preparation Identifying the need for change
AN ECONOMIC ANALYSIS OF VISVESVARYA URBAN COOPERATIVE BANK
62 AN ECONOMIC ANALYSIS OF VISVESVARYA URBAN COOPERATIVE BANK K. Ravichadra, Deputy Director, Istitute of Cooperative Maagemet, Thiruvaathapuram. V. Alagu Padia, Faculty Member, Istitute of Cooperative
INVESTMENT PERFORMANCE COUNCIL (IPC)
INVESTMENT PEFOMANCE COUNCIL (IPC) INVITATION TO COMMENT: Global Ivestmet Performace Stadards (GIPS ) Guidace Statemet o Calculatio Methodology The Associatio for Ivestmet Maagemet ad esearch (AIM) seeks
How to use what you OWN to reduce what you OWE
How to use what you OWN to reduce what you OWE Maulife Oe A Overview Most Caadias maage their fiaces by doig two thigs: 1. Depositig their icome ad other short-term assets ito chequig ad savigs accouts.
How to set up your GMC Online account
How to set up your GMC Olie accout Mai title Itroductio GMC Olie is a secure part of our website that allows you to maage your registratio with us. Over 100,000 doctors already use GMC Olie. We wat every
T H E N O N P R O F I T S E C T O R I N B R I E F :
URBAN INSTITUTE T H E N O N P R O F I T S E C T O R I N B R I E F : Public Charities, Givig, ad Voluteerig, 2012 Amy S. Blackwood, Katie L. Roeger, ad Sarah L. Pettijoh This brief summarizes ad expads
CHAPTER 3 THE TIME VALUE OF MONEY
CHAPTER 3 THE TIME VALUE OF MONEY OVERVIEW A dollar i the had today is worth more tha a dollar to be received i the future because, if you had it ow, you could ivest that dollar ad ear iterest. Of all
Young heroes of work life
Young heroes of work life The Youth Barometer of Eastern Finland 2012 Work and Entrepreneurship Youth Barometer of Eastern Finland 2012 Why do we need the Youth Barometer of Eastern Finland? 4 5 Because
Forecasting techniques
2 Forecastig techiques this chapter covers... I this chapter we will examie some useful forecastig techiques that ca be applied whe budgetig. We start by lookig at the way that samplig ca be used to collect
I. Chi-squared Distributions
1 M 358K Supplemet to Chapter 23: CHI-SQUARED DISTRIBUTIONS, T-DISTRIBUTIONS, AND DEGREES OF FREEDOM To uderstad t-distributios, we first eed to look at aother family of distributios, the chi-squared distributios.
Ideate, Inc. Training Solutions to Give you the Leading Edge
Ideate, Ic. Traiig News 2014v1 Ideate, Ic. Traiig Solutios to Give you the Leadig Edge New Packages For All Your Traiig Needs! Bill Johso Seior MEP - Applicatio Specialist Revit MEP Fudametals Ad More!
A guide to School Employees' Well-Being
A guide to School Employees' Well-Beig Backgroud The public school systems i the Uited States employ more tha 6.7 millio people. This large workforce is charged with oe of the atio s critical tasks to
MOTORING lim. Jinland
MOTORING lim Jinland " Photographs by Aho & Soldan, Ilmavoimat, Rasmussen, Runeberg, Pietinen. Copyright by SuomenMatkat/FinlandTravel, Helsinki. the An exciting moment car crossing the Arctic Circle.
Flood Emergency Response Plan
Flood Emergecy Respose Pla This reprit is made available for iformatioal purposes oly i support of the isurace relatioship betwee FM Global ad its cliets. This iformatio does ot chage or supplemet policy
Is there employment discrimination against the disabled? Melanie K Jones i. University of Wales, Swansea
Is there employmet discrimiatio agaist the disabled? Melaie K Joes i Uiversity of Wales, Swasea Abstract Whilst cotrollig for uobserved productivity differeces, the gap i employmet probabilities betwee
CHAPTER 3 DIGITAL CODING OF SIGNALS
CHAPTER 3 DIGITAL CODING OF SIGNALS Computers are ofte used to automate the recordig of measuremets. The trasducers ad sigal coditioig circuits produce a voltage sigal that is proportioal to a quatity
1. C. The formula for the confidence interval for a population mean is: x t, which was
s 1. C. The formula for the cofidece iterval for a populatio mea is: x t, which was based o the sample Mea. So, x is guarateed to be i the iterval you form.. D. Use the rule : p-value
2014 Menu of Agency Support Services 17 TOP OF MIND TOUCH POINTS
2014 Meu of Agecy Support Services 17 TOP OF MIND TOUCH POINTS Table of Cotets Turig a moolie customer ito a multi-lie customer icreases retetio by 7x! ORGANIC GROWTH Policy Reewal Appoitmet Calls.4 Life
Finnish Experiences of the EAFRD and Programme Based Rural Development 16.4.2010 Reykjavik
Finnish Experiences of the EAFRD and Programme Based Rural Development 16.4.2010 Reykjavik Ministerial Adviser Sirpa Karjalainen MAF, Finland [email protected] www.mmm.fi/en 1 case Finland Preparation
Z-TEST / Z-STATISTIC: used to test hypotheses about. µ when the population standard deviation is unknown
Z-TEST / Z-STATISTIC: used to test hypotheses about µ whe the populatio stadard deviatio is kow ad populatio distributio is ormal or sample size is large T-TEST / T-STATISTIC: used to test hypotheses about
PENSION ANNUITY. Policy Conditions Document reference: PPAS1(7) This is an important document. Please keep it in a safe place.
PENSION ANNUITY Policy Coditios Documet referece: PPAS1(7) This is a importat documet. Please keep it i a safe place. Pesio Auity Policy Coditios Welcome to LV=, ad thak you for choosig our Pesio Auity.
Generated by Foxit PDF Creator Foxit Software http://www.foxitsoftware.com For evaluation only.
FINLAND LAKES Number Code Release Date Price Class Status * W9 M-EN-M326.17 17 Feb 2011 Wide UPDATED SCALE CODE CHART NAME STATUS ** 1:3000000 CMP / 910A04W World Background - A 1:3000000 CMP / 910A04X
Data Analysis and Statistical Behaviors of Stock Market Fluctuations
44 JOURNAL OF COMPUTERS, VOL. 3, NO. 0, OCTOBER 2008 Data Aalysis ad Statistical Behaviors of Stock Market Fluctuatios Ju Wag Departmet of Mathematics, Beijig Jiaotog Uiversity, Beijig 00044, Chia Email:
EUROCONTROL PRISMIL. EUROCONTROL civil-military performance monitoring system
EUROCONTROL PRISMIL EUROCONTROL civil-military performace moitorig system Itroductio What is PRISMIL? PRISMIL is a olie civil-military performace moitorig system which facilitates the combied performace
Divestment of Anttila Oy to 4K INVEST. Media conference 16 Mar. 2015 President and CEO Mikko Helander
Divestment of Anttila Oy to 4K INVEST Media conference 16 Mar. 2015 President and CEO Mikko Helander Anttila Oy s share capital has been sold to 4K INVEST The transaction includes: 23 Anttila department
Detecting Voice Mail Fraud. Detecting Voice Mail Fraud - 1
Detectig Voice Mail Fraud Detectig Voice Mail Fraud - 1 Issue 2 Detectig Voice Mail Fraud Detectig Voice Mail Fraud Several reportig mechaisms ca assist you i determiig voice mail fraud. Call Detail Recordig
OMG! Excessive Texting Tied to Risky Teen Behaviors
BUSIESS WEEK: EXECUTIVE EALT ovember 09, 2010 OMG! Excessive Textig Tied to Risky Tee Behaviors Kids who sed more tha 120 a day more likely to try drugs, alcohol ad sex, researchers fid TUESDAY, ov. 9
Convention Paper 6764
Audio Egieerig Society Covetio Paper 6764 Preseted at the 10th Covetio 006 May 0 3 Paris, Frace This covetio paper has bee reproduced from the author's advace mauscript, without editig, correctios, or
